港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

藥捷安康-B

176.200

-15.800-8.23%

成交量：257.35萬

成交額：4.90億

市值：699.51億

市盈率：-224.55

高：210.000

開：198.800

低：175.300

收：192.000

52周最高：679.500

52周最低：20.200

股本：3.97億

香港流通股本：3.02億

量比：0.59

換手率：0.85%

股息：- -

股息率：- -

每股收益(LYR):-0.785

淨資產收益率：-39.08%

總資產收益率：-21.10%

市淨率：110.18

市盈率(LYR):-224.55

市銷率: - -

資料載入中...

總覽公司新聞公告

港股異動 | 藥捷安康-B(02617.HK)漲超50%破頂不到三個月股價飆漲21倍總市值突破1100億港元

藥捷安康低開高走漲近50%，創上市以來新高

老虎资讯综合

港股午評|恒生指數早盤漲0.29% CRO概念股走高

港股異動 | 藥捷安康(02617.HK)早盤重挫18% 總市值不足700億港元上半年集團未取得主營業務收入

0營收還虧損1.23億元，61歲南大校友掌舵的港股藥企，憑什麼撐起700億市值

一則臨牀進展公告拉動480億港元市值！創新藥「十倍股」藥捷安康的「臨牀故事」，真有這麼高含金量？

每日经济新闻

上半年營收為0，虧損1.23億元，藥捷安康股價一天大漲77%，市值達764億港元

每日经济新闻

刷屏！暴漲超130% 發生了什麼？

海外消費週報：關注高教政策推進辦學投入拐點顯現經營效率提升可期

申万宏源研究

藥捷安康盤中上漲超120%，市值逼近千億港元核心管線替恩戈替尼剛獲批一項臨牀試驗

每日经济新闻

港股異動 | 藥捷安康-B(02617.HK)尾盤迴落收漲77.09% 全天成交額超26億港元換手率約4.74%

港股異動 | 藥捷安康-B(02617.HK)午後漲近88% 較招股價已漲超14倍總市值一度突破800億港元

藥捷安康-B日內漲幅擴大逾120%！該股自上市以來累漲逾1600%

老虎资讯综合

港股異動 | 藥捷安康-B(02617.HK)再漲超18% 總市值突破500億港元替恩戈替尼乳癌II期試驗獲批

《全日速報》恒指全日收報26,086點跌113點; 恒生科技指數全日收報5,888點跌13點美團跌逾5% 萬洲、紫金礦業、匯控、周大福、藥捷安康－Ｂ創新高成交暢旺

阿斯达克财经

港股異動 | 藥捷安康-B(02617.HK)再漲超15% 總市值突破400億港元替恩戈替尼II期臨牀試驗獲批開展

藥捷安康-B股價再刷上市以來新高！核心產品II期臨牀試驗獲批開展

老虎资讯综合

藥捷安康-B(02617)：替恩戈替尼聯合氟維司羣治療經治失敗的HR陽性╱HER2陰性或低表達的復發或轉移性乳腺癌II期臨牀試驗獲批開展

Transthera Sciences (Nanjing) Inc獲得NMPA批准開展替尼諾替尼聯合療法II期試驗

港股收盤恒生指數漲1.01%恒生科技指數漲1.27%。港股科技ETF（159751）漲0.43%恒生港股通ETF（159

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02617/news?page=5"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02617","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","market":"HK","secType":"STK","nameCN":"藥捷安康-B","latestPrice":176.2,"timestamp":1761197380111,"preClose":192,"halted":0,"volume":2574501,"delay":0,"floatShares":301666673,"shares":397000000,"eps":-0.7846823312971165,"marketStatus":"交易中","change":-15.8,"latestTime":"10-23 13:29:40","open":198.8,"high":210,"low":175.3,"amount":489747892,"amplitude":0.180729,"askPrice":176.2,"askSize":1500,"bidPrice":176,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.6769405737778813,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1761207000000},"marketStatusCode":2,"adr":0,"listingDate":1750608000000,"exchange":"SEHK","adjPreClose":192,"openAndCloseTimeList":[[1761183000000,1761192000000],[1761195600000,1761206400000]],"volumeRatio":0.589129,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02617\",,,,,undefined,":{"symbol":"02617","floatShares":301666673,"roa":"-21.10%","roe":"-39.08%","lyrEps":-0.784682,"volumeRatio":0.5889,"shares":397000000,"dividePrice":0,"high":210,"amplitude":0.180729,"preClose":192,"low":175.3,"week52Low":20.2,"pbRate":"110.18","week52High":679.5,"institutionHeld":0,"latestPrice":176.2,"committee":-0.428571,"eps":-0.7846823312971165,"divideRate":0,"volume":2573501,"delay":0,"ttmEps":-0.6769405737778813,"open":198.8,"prevYearClose":13.15,"prevWeekClose":203,"prevMonthClose":141.2,"prevQuarterClose":141.2,"fiveDayClose":166.1,"twentyDayClose":165.1,"sixtyDayClose":40.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02617\",params:#limit:5,,,undefined,":[{"date":"2025-08-25","symbol":"02617","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756085400000,"name":null,"time":"","dateTimestamp":1756051200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02617\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02617\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02617\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02617","date":"2025-10-22","current":-264.757305,"percent":0.035294,"low":-380.446233,"twenty":-191.456594,"median":-60.667237,"eighty":-42.017389,"high":-17.403134,"avg":-105.13191,"sd":84.561944,"marketCap":76204345536},"quantilePoints":[{"date":"2025-06-20","current":-17.403134,"twenty":-17.403134,"median":-17.403134,"eighty":-17.403134,"marketCap":5219203873},{"date":"2025-06-27","current":-36.622688,"twenty":-34.709071,"median":-32.493198,"eighty":-31.066553,"marketCap":11013909315},{"date":"2025-07-04","current":-44.802949,"twenty":-38.622694,"median":-35.660049,"eighty":-31.776499,"marketCap":13474674640},{"date":"2025-07-11","current":-39.630155,"twenty":-40.38446,"median":-38.336544,"eighty":-32.816725,"marketCap":11906928990},{"date":"2025-07-18","current":-43.957869,"twenty":-42.111612,"median":-39.630155,"eighty":-34.373739,"marketCap":13196846297},{"date":"2025-07-25","current":-49.067594,"twenty":-42.195906,"median":-40.285196,"eighty":-36.230637,"marketCap":14784436829},{"date":"2025-08-01","current":-50.963195,"twenty":-45.655878,"median":-41.371359,"eighty":-36.620356,"marketCap":15260713988},{"date":"2025-08-08","current":-58.015216,"twenty":-51.234741,"median":-42.017389,"eighty":-37.993773,"marketCap":17415868136},{"date":"2025-08-15","current":-66.867935,"twenty":-57.065221,"median":-42.261724,"eighty":-38.707864,"marketCap":20043330466},{"date":"2025-08-22","current":-72.723484,"twenty":-59.09189,"median":-43.957869,"eighty":-39.464263,"marketCap":21730145406},{"date":"2025-08-29","current":-49.610789,"twenty":-64.458089,"median":-47.896219,"eighty":-39.630155,"marketCap":21492006826},{"date":"2025-09-05","current":-57.867887,"twenty":-63.405379,"median":-50.300475,"eighty":-39.739866,"marketCap":25044240642},{"date":"2025-09-12","current":-176.221101,"twenty":-67.557018,"median":-51.642061,"eighty":-40.181616,"marketCap":76402794352},{"date":"2025-09-19","current":-137.321051,"twenty":-71.134174,"median":-54.042597,"eighty":-40.68225,"marketCap":59494955186},{"date":"2025-09-26","current":-219.814439,"twenty":-72.736767,"median":-55.62397,"eighty":-41.23574,"marketCap":56835741045},{"date":"2025-10-03","current":-208.418403,"twenty":-113.88308,"median":-57.213624,"eighty":-41.375772,"marketCap":54017767851},{"date":"2025-10-10","current":-183.264838,"twenty":-172.633767,"median":-57.790453,"eighty":-41.583173,"marketCap":47429267143},{"date":"2025-10-17","current":-311.562728,"twenty":-178.967921,"median":-58.015216,"eighty":-41.927636,"marketCap":80570219499},{"date":"2025-10-22","current":-294.68471,"twenty":-191.456594,"median":-60.667237,"eighty":-42.017389,"marketCap":76204345536}],"updateTime":1761193202922},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02617\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2567719347","title":"港股異動 | 藥捷安康-B(02617.HK)漲超50%破頂 不到三個月股價飆漲21倍 總市值突破1100億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567719347","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567719347?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 13:51","pubTimestamp":1757915492,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"1138498450","title":"藥捷安康低開高走漲近50%，創上市以來新高","url":"https://stock-news.laohu8.com/highlight/detail?id=1138498450","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138498450?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 13:16","pubTimestamp":1757913398,"startTime":"0","endTime":"0","summary":"9月15日（周一），药捷安康低开高走涨近50%，创上市以来新高，前7个交易日狂飙逾360%！","market":"us","thumbnail":"https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/d17cb0ea313437e7afb8bad7f25dce9a"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5144c09c2993e0c7de4c76f1c2196293","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2567167035","title":"港股午評|恒生指數早盤漲0.29%    CRO概念股走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2567167035","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567167035?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 12:00","pubTimestamp":1757908804,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，港股恒生指数涨0.29%，涨75点，报26463点；恒生科技指数涨1.11%。港股早盘成交1620亿港元。药捷安康再涨超33%，药捷安康被调入港股通标的名单，自9月8日起生效。锂电池板块涨幅居前，大摩发研报唱好宁德时代，机构称市场关注锂电明年需求预期。沪上阿姨涨超8%，公司近期获纳入港股通名单，上半年门店数量平稳增长。9月8日起，脑动极光正式获纳入港股通名单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1345108.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06681","HSImain","02833","02617","513600","BK1584","159271","HHImain","HSCEI","HSI","BK4614","YANG","MHImain","HSTECH","00376","BK1161","BK1501","BK1184","BK1189","MCHmain"],"gpt_icon":1},{"id":"2567016177","title":"港股異動 | 藥捷安康(02617.HK)早盤重挫18% 總市值不足700億港元 上半年集團未取得主營業務收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2567016177","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567016177?lang=zh_tw&edition=fundamental","pubTime":"2025-09-15 10:07","pubTimestamp":1757902056,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2567565561","title":"0營收還虧損1.23億元，61歲南大校友掌舵的港股藥企，憑什麼撐起700億市值","url":"https://stock-news.laohu8.com/highlight/detail?id=2567565561","media":"鱼禾财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567565561?lang=zh_tw&edition=fundamental","pubTime":"2025-09-14 19:07","pubTimestamp":1757848039,"startTime":"0","endTime":"0","summary":"没有主营收入还亏损1.23亿元靠一款创新药持续发力虽然在港股一路狂飙、市值一度逼近千亿，但与大多数生物科技公司一样，药捷安康目前还没有商业化产品，业绩处在亏损中。今年上半年，药捷安康依旧没有主营业务收入，其他收入及收益由2024年的1040万元下降至360万元，降幅达65.1%。此外，药捷安康上半年录得税前亏损1.23亿元，相较于2024年同期亏损的1.6亿元有所改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091419203597913440&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091419203597913440&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","02617","HSCEI"],"gpt_icon":1},{"id":"2567115584","title":"一則臨牀進展公告拉動480億港元市值！創新藥「十倍股」藥捷安康的「臨牀故事」，真有這麼高含金量？","url":"https://stock-news.laohu8.com/highlight/detail?id=2567115584","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567115584?lang=zh_tw&edition=fundamental","pubTime":"2025-09-14 18:13","pubTimestamp":1757844789,"startTime":"0","endTime":"0","summary":"截至当日收盘，药捷安康总市值达到764亿港元，排在港股创新药板块第12位。公司股价近期的上涨，起始于9月10日披露核心产品替恩戈替尼一项临床试验获得临床默示许可的公告，此后3个交易日，市值激增近480亿港元。一则公告拉动480亿港元市值？获得该许可，意味着经过60个公示日后，药捷安康可以按照提交的方案启动II期临床试验。9月14日，药捷安康相关人士表示，暂时不方便接受采访。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250914181615a4c5721a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250914181615a4c5721a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1574","06978","BK1161"],"gpt_icon":1},{"id":"2567189312","title":"上半年營收為0，虧損1.23億元，藥捷安康股價一天大漲77%，市值達764億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567189312","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567189312?lang=zh_tw&edition=fundamental","pubTime":"2025-09-13 12:51","pubTimestamp":1757739060,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　9月12日开盘，药捷安康一路上涨，盘中最高达到251.40港元/股，涨幅超130%，总市值一度逼近千亿港元，截至当日收盘，公司股价大涨77%，市值为764.03亿港元。　　与多数Biotech一样，药捷安康目前还没有商业化产品，今年上半年，公司的营业收入为0，亏损1.23亿元，公司主要管线包括6款临床阶段候选产品及多款临床前阶段候选产品，其中，替恩戈替尼是核心产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2025-09-13/doc-infqimam6745467.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-09-13/doc-infqimam6745467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02617"],"gpt_icon":0},{"id":"2567900646","title":"刷屏！暴漲超130% 發生了什麼？","url":"https://stock-news.laohu8.com/highlight/detail?id=2567900646","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567900646?lang=zh_tw&edition=fundamental","pubTime":"2025-09-13 07:25","pubTimestamp":1757719546,"startTime":"0","endTime":"0","summary":"一只港股次新股刷屏了！9月12日，药捷安康-B(02617.HK)午后持续冲高，盘中一度涨超130%，最近3个交易日，涨幅达2倍。该股上市还不到3个月时间，股价已飙升超18倍，市值一度达到997亿港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202509133512702444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"2567018205","title":"海外消費週報：關注高教政策推進 辦學投入拐點顯現 經營效率提升可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2567018205","media":"申万宏源研究","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567018205?lang=zh_tw&edition=fundamental","pubTime":"2025-09-13 00:00","pubTimestamp":1757692800,"startTime":"0","endTime":"0","summary":"过去5 年民办高校办学投入持续增长，经营效益持续恶化。因此收入增速持续放缓。伴随办学投入及资本开支见顶，高教公司派息恢复也值得期待。营利性政策的推进，将保障高校公司对办学收益的分配权益。研究结果显示，在137 例既往接受过治疗的ES-SCLC 患者中，ORR 为48.2%、DCR 为87.6%、mPFS为4.9 个月、mOS 为10.3 个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250913202056978f8153&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250913202056978f8153&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00013","BK1161","02617","02001"],"gpt_icon":1},{"id":"2566977105","title":"藥捷安康盤中上漲超120%，市值逼近千億港元 核心管線替恩戈替尼剛獲批一項臨牀試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2566977105","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566977105?lang=zh_tw&edition=fundamental","pubTime":"2025-09-12 22:16","pubTimestamp":1757686615,"startTime":"0","endTime":"0","summary":"每经记者｜林姿辰    每经编辑｜魏官红9月12日开盘，药捷安康一路上涨，盘中最高达到251.40港元/股，总市值一度逼近千亿港元，截至当日收盘，公司市值为764.03亿港元。截至6月30日，替恩戈替尼在全球已进行或正在进行共9项公司发起的临床试验，其中2项临床试验在健康受试者中进行，7项临床试验在实体瘤患者中进行。不过，2023年，LG Chem与药捷安康同意终止该对外授权安排，招股书中并未披露终止原因。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250912221724a4c2ea3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"07d006678791573abfcbda7f1d8c4a2f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250912221724a4c2ea3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02617","BK1161"],"gpt_icon":1},{"id":"2566921601","title":"港股異動 | 藥捷安康-B(02617.HK)尾盤迴落收漲77.09% 全天成交額超26億港元 換手率約4.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566921601","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566921601?lang=zh_tw&edition=fundamental","pubTime":"2025-09-12 16:10","pubTimestamp":1757664612,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"07d006678791573abfcbda7f1d8c4a2f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"2566940744","title":"港股異動 | 藥捷安康-B(02617.HK)午後漲近88% 較招股價已漲超14倍 總市值一度突破800億港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566940744","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566940744?lang=zh_tw&edition=fundamental","pubTime":"2025-09-12 13:39","pubTimestamp":1757655563,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"07d006678791573abfcbda7f1d8c4a2f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02617"],"gpt_icon":0},{"id":"1109419271","title":"藥捷安康-B日內漲幅擴大逾120%！該股自上市以來累漲逾1600%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109419271","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109419271?lang=zh_tw&edition=fundamental","pubTime":"2025-09-12 13:17","pubTimestamp":1757654231,"startTime":"0","endTime":"0","summary":"9月12日，$药捷安康-B(02617)$盘初再飙逾18%，股价续刷上市以来新高，总市值突破500亿港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"07d006678791573abfcbda7f1d8c4a2f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"药捷安康-B股价续刷新高，上市以来累涨逾1200%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2566949544","title":"港股異動 | 藥捷安康-B(02617.HK)再漲超18% 總市值突破500億港元 替恩戈替尼乳癌II期試驗獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2566949544","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566949544?lang=zh_tw&edition=fundamental","pubTime":"2025-09-12 09:57","pubTimestamp":1757642264,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"07d006678791573abfcbda7f1d8c4a2f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2566685229","title":"《全日速報》恒指全日收報26,086點 跌113點; 恒生科技指數全日收報5,888點 跌13點 美團跌逾5% 萬洲、紫金礦業、匯控、周大福、藥捷安康－Ｂ創新高 成交暢旺","url":"https://stock-news.laohu8.com/highlight/detail?id=2566685229","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566685229?lang=zh_tw&edition=fundamental","pubTime":"2025-09-11 16:12","pubTimestamp":1757578320,"startTime":"0","endTime":"0","summary":"恒指全日收26,086点，跌113点或0.4%。恒生科技指数报5,888点，跌13点或0.2%。国指跌67点或0.7%，报9,260点。大市成交额3,252.05亿元。沽空资料截至 2025-09-11 16:25。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725103754138_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725103754138_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1469686/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["601899","LU0348814723.USD","HSI","HSHD.SI","HK0000320264.USD","LU1807302812.USD","02617","LU0463099449.HKD","LU1008478684.HKD","SG9999002463.SGD","SG9999002562.SGD","LU0572944931.SGD","LU1831875114.USD","03143","LU0210526637.USD","HHImain","LU0828237510.HKD","HSBA.UK","00005","LU0049853897.USD","LU0370786039.SGD","LU0737861699.HKD","02833","HSImain","BK0077","03690","LU0011963245.USD","LU0611395673.USD","IE0008369823.USD","HSBC","LU1282648689.USD","METmain","LU0039217434.USD","LU0048580855.USD","LU2045819591.USD","LU1048588211.SGD","HMTD.SI","HSTECH","SG9999001903.USD","LU0531971595.HKD","513600","LU0348816934.USD","LU2148510915.USD","02899","BK1610","LU0868486357.SGD","MHImain","01929","MPNGY","MCHmain"],"gpt_icon":0},{"id":"2566376699","title":"港股異動 | 藥捷安康-B(02617.HK)再漲超15% 總市值突破400億港元 替恩戈替尼II期臨牀試驗獲批開展","url":"https://stock-news.laohu8.com/highlight/detail?id=2566376699","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566376699?lang=zh_tw&edition=fundamental","pubTime":"2025-09-11 10:50","pubTimestamp":1757559047,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"603793f027d63040f5e30da5bde0c993","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02617","BK1161"],"gpt_icon":0},{"id":"1131617722","title":"藥捷安康-B股價再刷上市以來新高！核心產品II期臨牀試驗獲批開展","url":"https://stock-news.laohu8.com/highlight/detail?id=1131617722","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131617722?lang=zh_tw&edition=fundamental","pubTime":"2025-09-11 10:44","pubTimestamp":1757558663,"startTime":"0","endTime":"0","summary":"9月11日，$药捷安康-B$盘中强势拉升，现涨近18%，股价再刷上市以来新高。药捷安康-B公布，公司核心产品替恩戈替尼联合氟维司群治疗经治失败的激素受体阳性(HR+)且人表皮生长因子受体2阴性或低表达的复发或转移性乳腺癌II期临床试验，已于2025年9月 10日获得了中国国家药品监督管理局的临床默示许可。临床前实验结果表明，替恩戈替尼与氟维司群的联合用药针对内分泌治疗耐药的乳腺癌细胞具有药理学协同作用。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"603793f027d63040f5e30da5bde0c993","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"药捷安康-B股价再刷上市以来新高！核心产品II期临床试验获批开展","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617"],"gpt_icon":0},{"id":"2566668602","title":"藥捷安康-B(02617)：替恩戈替尼聯合氟維司羣治療經治失敗的HR陽性╱HER2陰性或低表達的復發或轉移性乳腺癌II期臨牀試驗獲批開展","url":"https://stock-news.laohu8.com/highlight/detail?id=2566668602","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566668602?lang=zh_tw&edition=fundamental","pubTime":"2025-09-10 21:50","pubTimestamp":1757512252,"startTime":"0","endTime":"0","summary":"本试验为在中国开展的一项评价替恩戈替尼片联合氟维司群注射液用于经治失败的HR+/HER2-的复发或转移性乳腺癌患者的安全性、疗效及药代动力学的开放标签、多中心、II期临床研究。临床前实验结果表明，替恩戈替尼与氟维司群的联合用药针对内分泌治疗耐药的乳腺癌细胞具有药理学协同作用。因此替恩戈替尼联合氟维司群的临床治疗策略将可能为此类乳腺癌患者的治疗带来新的突破。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1343826.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02617","BK4225","BK4203","HR"],"gpt_icon":1},{"id":"1180858364","title":"Transthera Sciences (Nanjing) Inc獲得NMPA批准開展替尼諾替尼聯合療法II期試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=1180858364","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180858364?lang=zh_tw&edition=fundamental","pubTime":"2025-09-10 21:49","pubTimestamp":1757512161,"startTime":"0","endTime":"0","summary":"Transthera Sciences (Nanjing) Inc（药捷安康-B）已获得国家药品监督管理局(NMPA)批准，可开展替尼诺替尼联合疗法的II期临床试验。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BK1161"],"gpt_icon":0},{"id":"2566675070","title":"港股收盤恒生指數漲1.01%恒生科技指數漲1.27%。港股科技ETF（159751）漲0.43%恒生港股通ETF（159","url":"https://stock-news.laohu8.com/highlight/detail?id=2566675070","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566675070?lang=zh_tw&edition=fundamental","pubTime":"2025-09-10 16:10","pubTimestamp":1757491806,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1282649067.USD","LU0244354667.USD","JD","LU1481107354.HKD","BK4504","LU0871576103.HKD","LNVGY","IE0034224299.USD","513600","CFA.SI","SUHJY","HSTECH","159837","02617","03145","02833","02473","IE0032431581.USD","09618","HHImain","YANG","00016","REIT","80992","LU0499858438.USD","HSCEI","LU2088748020.USD","MCHmain","LU0594300419.USD","01530","LU0307460666.USD","00992","80016","07226","513020","BK4585","159751","159271","LU1188198961.HKD","MHImain","159318","LU0348735423.USD","09678","89618","513990","LU0488056044.USD","HSI","03121","159227","HSImain"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":181,"code":"91000000","status":"200"}]}}